Michael J. Thomas

9.6k citations
141 papers · 6.9k · 2 hit papers · h-index 45

Impact in

Papers in

    • Peroxisome Proliferator-Activated Receptors 21
    • Lipid Membrane Structure and Behavior 8
    • Cholesterol and Lipid Metabolism 32
    • Lipoproteins and Cardiovascular Health 10

Michael J. Thomas

136 papers receiving 6.7k citations

Hit Papers

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer 2016 · 397 citations
3970+7+14Years since publication100200300400500

Peers

Michael J. Thomas
Comparison fields: 5 of 161
  • Internal Medicine 387
  • Endocrinology, Diabetes and Metabolism 1.4k
  • Immunology 1.3k
  • Cancer Research 661
  • Oncology 1.2k
Replace Leonard Kritharides with:
Leonard Kritharides Australia
Paolo Gresele Italy
Johannes Oldenburg Germany
Chiara Cerletti Italy
D. Seidel Germany
Jane E. Freedman United States
Victor W. Armstrong Germany
Aaron J. Marcus United States
Petr Jarolı́m United States
J. F. Mustard Canada
Michael J. Thomas relative to Leonard Kritharides Australia Leonard Kritharides's profile →
Citations per field
00.5×1.6×
Leonard Kritharides · 1×
Citations per year

Countries citing papers authored by Michael J. Thomas

Since Specialization
Citations

This map shows the geographic impact of Michael J. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Thomas more than expected).

Fields of papers citing papers by Michael J. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Thomas. The network helps show where Michael J. Thomas may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael J. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. Thomas Line = papers co-authored together Michael J. Thomas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)
Hit paper breakdown →
2004519
2
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
Hit paper breakdown →
2016397
3 2010275
4 2011271
5 2013255
6 1988234
7 2017201
8 2000180
9 2002150
10 2016137
11 2012132
12 2018130
13 2008113
14 2010108
15 2009106
16 2019105
17 2012102
18 2007100
19 201393
20 200890

About Michael J. Thomas

Michael J. Thomas is a scholar working on Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism, Oncology and Epidemiology, having authored 141 papers that have together received 6.9k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (32 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers), Peroxisome Proliferator-Activated Receptors (21 papers), Atherosclerosis and Cardiovascular Diseases (11 papers), Lipoproteins and Cardiovascular Health (10 papers), Lipid metabolism and biosynthesis (9 papers), Growth Hormone and Insulin-like Growth Factors (9 papers) and Lipid Membrane Structure and Behavior (8 papers). The work is most often cited by research in Internal Medicine (387 citations), Endocrinology, Diabetes and Metabolism (1.4k citations), Immunology (1.3k citations), Cancer Research (661 citations) and Oncology (1.2k citations). Michael J. Thomas has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Mary G. Sorci‐Thomas, Shaila Bhat, John A. Thomas, John S. Parks, J.S. Owen, Peter Rotwein, Michael P. Samuel, Xuewei Zhu, Gwendalyn J. Randolph and R C N Williamson. Their work appears in journals such as Journal of Lipid Research, Journal of Biological Chemistry, Biochemistry, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact